283 related articles for article (PubMed ID: 8237910)
1. Gene therapy.
Levine F; Friedmann T
Am J Dis Child; 1993 Nov; 147(11):1167-74. PubMed ID: 8237910
[No Abstract] [Full Text] [Related]
2. [Current status of gene therapy and viral vectors].
Ozawa K
Uirusu; 1997 Dec; 47(2):195-201. PubMed ID: 9545865
[No Abstract] [Full Text] [Related]
3. Improvements in adenoviral vector technology: overcoming barriers for gene therapy.
Parks RJ
Clin Genet; 2000 Jul; 58(1):1-11. PubMed ID: 10945654
[No Abstract] [Full Text] [Related]
4. Viral vectors for gene transfer: a review of their use in the treatment of human diseases.
Walther W; Stein U
Drugs; 2000 Aug; 60(2):249-71. PubMed ID: 10983732
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy and vascular disease.
Kibbe M; Billiar T; Tzeng E
Adv Pharmacol; 1999; 46():85-150. PubMed ID: 10332502
[No Abstract] [Full Text] [Related]
6. The design of vectors for RNAi delivery system.
Wang QZ; Lv YH; Diao Y; Xu R
Curr Pharm Des; 2008; 14(13):1327-40. PubMed ID: 18537656
[TBL] [Abstract][Full Text] [Related]
7. Emerging adenoviral vectors for stable correction of genetic disorders.
Jager L; Ehrhardt A
Curr Gene Ther; 2007 Aug; 7(4):272-83. PubMed ID: 17969560
[TBL] [Abstract][Full Text] [Related]
8. HSV-1 amplicon vectors--simplicity and versatility.
Sena-Esteves M; Saeki Y; Fraefel C; Breakefield XO
Mol Ther; 2000 Jul; 2(1):9-15. PubMed ID: 10899823
[No Abstract] [Full Text] [Related]
9. Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo.
Bilbao G; Feng M; Rancourt C; Jackson WH; Curiel DT
FASEB J; 1997 Jul; 11(8):624-34. PubMed ID: 9240964
[TBL] [Abstract][Full Text] [Related]
10. Overview of the retrovirus transduction system.
Cepko C; Pear W
Curr Protoc Mol Biol; 2001 May; Chapter 9():Unit9.9. PubMed ID: 18265289
[TBL] [Abstract][Full Text] [Related]
11. Progresses towards safe and efficient gene therapy vectors.
Chira S; Jackson CS; Oprea I; Ozturk F; Pepper MS; Diaconu I; Braicu C; Raduly LZ; Calin GA; Berindan-Neagoe I
Oncotarget; 2015 Oct; 6(31):30675-703. PubMed ID: 26362400
[TBL] [Abstract][Full Text] [Related]
12. Construction of multiply disabled herpes simplex viral vectors for gene delivery to the nervous system.
Lilley CE; Coffin RS
Methods Mol Med; 2003; 76():33-49. PubMed ID: 12526157
[No Abstract] [Full Text] [Related]
13. Gene transfer by viral vectors for gene therapy.
Becker Y; Darai G
J Mol Med (Berl); 1995 Mar; 73(3):103-5. PubMed ID: 7633945
[No Abstract] [Full Text] [Related]
14. [Viral gene transfer medicinal products. Therapy with "disarmed" human pathogens].
Winckler T
Pharm Unserer Zeit; 2011 May; 40(3):202-11. PubMed ID: 21698609
[No Abstract] [Full Text] [Related]
15. Adenovirus and adeno-associated virus as vectors for gene therapy.
Berns KI; Giraud C
Ann N Y Acad Sci; 1995 Nov; 772():95-104. PubMed ID: 8546417
[No Abstract] [Full Text] [Related]
16. Gene therapy 1995: developments on the horizon.
Glorioso J
Gene Ther; 1995 Mar; 2(2):81-3. PubMed ID: 7719934
[No Abstract] [Full Text] [Related]
17. Treatment of human disease by adeno-associated viral gene transfer.
Warrington KH; Herzog RW
Hum Genet; 2006 Jul; 119(6):571-603. PubMed ID: 16612615
[TBL] [Abstract][Full Text] [Related]
18. [Gene therapy: new developments].
Mohr L; Geissler M
Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
[TBL] [Abstract][Full Text] [Related]
19. The challenges of recombinant adeno-associated virus manufacturing: alternative use of adeno-associated virus plasmid/liposome complexes for gene therapy applications.
Lebkowski JS; Okarma TB; Philip R
Curr Top Microbiol Immunol; 1996; 218():51-9. PubMed ID: 8794245
[No Abstract] [Full Text] [Related]
20. Development and optimization of adeno-associated virus vector transfer into the central nervous system.
During MJ; Young D; Baer K; Lawlor P; Klugmann M
Methods Mol Med; 2003; 76():221-36. PubMed ID: 12526166
[No Abstract] [Full Text] [Related]
[Next] [New Search]
